The state of North Dakota currently has 1 active clinical trials seeking participants for Atopic Dermatitis research studies. These trials are conducted in various cities, including Fargo, Bismarck, Grand Forks and Minot.
Safety, PK, PD, and Clinical Activity of Orally Administered KT-621 in Adult Patients With Atopic Dermatitis (AD)
Recruiting
This is a study to evaluate safety, tolerability, pharmacokinetics, pharmacodynamics, and clinical activity of orally administered KT-621 in adult male and female patients with moderate to severe atopic dermatitis (AD).
Gender:
ALL
Ages:
Between 18 years and 55 years
Trial Updated:
05/01/2025
Locations: Kymera Investigative Site, Fargo, North Dakota
Conditions: Atopic Dermatitis